| PERIOD ENDING | 29-Aug-09 | 30-Aug-08 | 25-Aug-07 | | Total Revenue | 50,484 | 78,256 | 116,233 | | Cost of Revenue | 34,057 | 45,271 | 69,110 | | | Gross Profit | 16,427 | 32,985 | 47,123 | | | Operating Expenses | | Research Development | 14,674 | 18,962 | 24,086 | | Selling General and Administrative | 19,504 | 29,012 | 34,542 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (17,751) | (14,989) | (11,505) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 84 | 870 | (2,986) | | Earnings Before Interest And Taxes | (17,667) | (14,119) | (14,491) | | Interest Expense | 41 | 144 |
-
| | Income Before Tax | (17,708) | (14,263) | (14,491) | | Income Tax Expense | (84) | (624) | 122 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (17,624) | (13,639) | (14,586) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (17,624) | (13,639) | (14,586) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($17,624) | ($13,639) | ($14,586) |
|
1.48% Nasdaq 
Income Statement
